Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-Src Tyrosine Kinase

Autor: Bogdan Ionel Tamba, Mihaela Dinu, Robert Ancuceanu, Cristina Silvia Stoicescu
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Quantitative structure–activity relationship
Molecular Conformation
Quantitative Structure-Activity Relationship
Computational biology
Molecular Dynamics Simulation
Catalysis
Article
drug discovery
Inorganic Chemistry
03 medical and health sciences
molecular descriptors
0302 clinical medicine
Molecular descriptor
Humans
cancer
Physical and Theoretical Chemistry
Molecular Biology
Protein Kinase Inhibitors
Spectroscopy
Virtual screening
Chemistry
Drug discovery
QSAR
Organic Chemistry
other
Reproducibility of Results
General Medicine
molecular docking
Models
Theoretical

chEMBL
virtual screening
Computer Science Applications
Molecular Docking Simulation
c-src-tyrosine kinase
030104 developmental biology
src-Family Kinases
Docking (molecular)
030220 oncology & carcinogenesis
Proto-oncogene tyrosine-protein kinase Src
Applicability domain
Protein Binding
Zdroj: International Journal of Molecular Sciences
Volume 21
Issue 1
DOI: 10.0113/v2
Popis: Prototype of a family of at least nine members, c-src tyrosine kinase is a therapeutically interesting target, because its inhibition might be of interest not only in a number of malignancies, but also in a diverse array of conditions, from neurodegenerative pathologies to certain viral infections. Computational methods in drug discovery are considerably cheaper than conventional methods and offer opportunities of screening very large numbers of compounds in conditions that would be simply impossible within the wet lab experimental settings. We have explored the use of global QSAR models and molecular ligand docking in the discovery of new c-src tyrosine kinase inhibitors. Using a data set of 1038 compounds from ChEMBL and 19 blocks of molecular descriptors, we have developed over 200 QSAR classification models, based on six machine learning algorithms and 17 feature selection methods. We have selected 49 with reasonably good performance (positive predictive value and balanced accuracy higher than 70% in nested cross validation) and the models were assembled by stacking with a simple majority vote and used for the virtual screening of over the “named” ZINC data set (over 100,000 compounds). 744 compounds were predicted by at least 50% of the QSAR models as active, 147 compounds were within the applicability domain and predicted by at least 75% of the models to be active. The latter 147 compounds were submitted to molecular ligand docking using Vina and Ledock, and a number of 90 were predicted to be active based on the binding energy. External data from CHEMBL and PUBCHEM confirmed that at least 7.83% (in the case of QSAR) or 6.67% (in the case of integrated QSAR and molecular docking) of the compounds are active on the c-src target.
Databáze: OpenAIRE